| Body na spoluautora | Body za publikaci pro MU | Odkaz ISVaV | | 6,46 | 83,94 | miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities.
|
| 13,03 | 91,18 | Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage.
|
| 1,24 | 11,16 | Microarray analysis using limited amount of cells
|
| 2,96 | 20,73 | Successful treatment of steroid-refractory hepatitic variant of liver graft-vs host disease with pulse cyclophosphamide
|
| 1,05 | 13,70 | Presence of heterozygous ATM deletion may not be critical in the primary response of chronic lymphocytic leukemia cells to fludarabine
|
| 8,78 | 35,14 | Retention of nanoparticules-labeled bone marrow mononuclear cells in the isolated ex vivo perfused heart after myocardial infarction in animal model
|
| 0,00 | 0,00 | Bone marrow stem cells in patients with chronic myeloid leukemia.
|
| 0,65 | 5,83 | Výsledky léčby nemocných s esenciální trombocytémií a dalšími myeloproliferacemi provázenými trombocytémií-zpráva z registru pacientů léčených Thromboreductinem
|
| 17,05 | 119,33 | Acute myeloid leukemias with reccurent genetic abnormalities: frequent assessment of minimal residual disease and treatment of molecular relaps with chemotherapy. Acute myeloid leukemias with reccurent genetic abnormalities: frequent assessment of minima
|
| 9,18 | 128,51 | CHARACTERIZATION OF P53 ABNORMALITIES IN B-CLL PATIENTS IN RELATION TO IGVH MUTATION STATUS AND PREVIOUS TREATMENT
|
| 0,00 | 0,00 | Charakterizace abnormalit v genech p53 a ATM u B-CLL pacientůbuněk
|
| 0,00 | 0,00 | Charakterizace abnormalit v genech p53 a ATM u B-CLL pacientů
|
| 1,40 | 8,42 | Intracoronary Delivery of Bone Marrow Cells of the Acutely Infarcted myokardium. Optimization of the Delivery Technique.
|
| 1,85 | 20,40 | Identification of somatic hypermutations in the TP53 gene in B-cell chronic lymphocytic leukemia
|
| 1,31 | 13,12 | Intracoronary delivery of bone marrow cells to the acutely infarcted myocardium
|
| 0,00 | 0,00 | Klonální evoluce u chronické lymfocytární leukemie
|
| 0,43 | 5,20 | Inactivation of p53 and amplification of MYCN gene in a terminal lymphoblastic relapse in a chronic lymphocytic leukemia patient
|
| 16,06 | 128,51 | Detection of molecular relapse of AML by very frequent quantitative monitoring of different molecular markers (Fusion transcripts and WTI) in different compartments (peripheral blood, bone marrow, and selected CD34+bone marrow cells) and its treatment...
|
| 0,94 | 1,87 | Distribuce autologních značených mononukleárních buněk kostní dřeně v postischemickém myokardu (ex vivo model králičího srdce)
|
| 0,00 | 0,00 | Inaktivace p53 u B-CLL pacientů ve vztahu k mutačnímu stavu IgVH a léčbě
|
| 0,00 | 0,00 | Inaktivace p53 u B-CLL pacientů ve vztahu k mutačnímu stavu IgVH a léčbě
|
| 1,08 | 14,00 | Inaktivace p53 a delece ATM v souboru B-CLL pacientů ve vztahu k mutačnímu statusu IgVH a léčbě
|
| 6,67 | 86,67 | Inactivation of p53 and deletion of ATM in B-CLL patients in relation to IgVH mutation
|
| 0,00 | 0,00 | Acute myeloid leukemia in the Czech Republic and the Slovak Republic from 1996 to 2007. Prognostic and therapeutic results of 1890 patients from the ALERT registry
|
| 0,00 | 0,00 | Co nám v každodenní praxi skutečně říkají tzv. moderní prognostické faktory u chronické lymfatické leukemie?
|
| 0,00 | 0,00 | Detekce mutace JAK2 V617F u myeloproliferativních onemocnění - přehled a vlastní zkušenosti
|
| 3,05 | 18,30 | Autologous hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: still not out of fashion
|
| 2,76 | 22,12 | Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: Frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression
|
| 0,80 | 3,20 | Is FLT3 internal tandem duplication significant indicator for allogeneic transplantation in acute myeloid leukemia? An analysis of patients from the Czech Acute Leukemia Clinical Register (ALERT)
|
| 0,00 | 0,00 | Terapeutické monoklonální protilátky senzitivizují in vitro některé B-CLL vzorky s aberacemi genu TP53 k fludarabinu a chlorambucilu
|
| 0,00 | 0,00 | Senzitivizace B-CLL vzorků in vitro na fludarabin a chlorambucil pomocí monoklonální protilátky rituximab
|
| 12,85 | 128,51 | Rituximab Senzitizes B-CLL Cells with Inactived p53 to fludarabine
|
Back
(c) Michal Bulant, 2011